Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system

S Gritsch, TT Batchelor, LN Gonzalez Castro - Cancer, 2022 - Wiley Online Library
The 2016 revised fourth edition of the World Health Organization (WHO) classification of
central nervous system (CNS) tumors incorporated molecular features with histologic …

World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review

TR Berger, PY Wen, M Lang-Orsini… - JAMA …, 2022 - jamanetwork.com
Importance Previous histologic classifications of brain tumors have been limited by
discrepancies in diagnoses reported by neuropathologists and variability in outcomes and …

Isocitrate dehydrogenase (IDH) mutant gliomas: a Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

JJ Miller, LN Gonzalez Castro, S McBrayer… - Neuro …, 2023 - academic.oup.com
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

K Singh, KM Hotchkiss, IF Parney, J De Groot… - Nature medicine, 2023 - nature.com
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling |
Nature Medicine Skip to main content Thank you for visiting nature.com. You are using a …

Nanoparticles hitchhike on monocytes for glioblastoma treatment after low-dose radiotherapy

J Kuang, ZY Rao, DW Zheng, D Kuang, QX Huang… - ACS …, 2023 - ACS Publications
Glioblastomas (GBMs) are aggressive primary brain tumors with fatal outcome. Traditional
chemo-radiotherapy has poor therapeutic effect and significant side effects, due to the drug …

Management of advanced human epidermal growth factor receptor 2–positive breast cancer and brain metastases: ASCO guideline update

N Ramakrishna, CK Anders, NU Lin… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide updated evidence-and consensus-based guideline
recommendations to practicing oncologists and others on the management of brain …

Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients

G Crisafulli, A Sartore-Bianchi, L Lazzari, F Pietrantonio… - Cancer Discovery, 2022 - AACR
The majority of metastatic colorectal cancers (mCRC) are mismatch repair (MMR) proficient
and unresponsive to immunotherapy, whereas MMR-deficient (MMRd) tumors often respond …

Signaling pathways and therapeutic approaches in glioblastoma multiforme

M Khabibov, A Garifullin… - International …, 2022 - spandidos-publications.com
Glioblastoma multiforme (GBM) is the most aggressive type of primary brain tumor and is
associated with a poor clinical prognosis. Despite the progress in the understanding of the …

Brain radiotherapy combined with targeted therapy for HER2-positive breast cancer patients with brain metastases

L Tang, W Zhang, L Chen - Breast Cancer: Targets and Therapy, 2024 - Taylor & Francis
Background Research on the sequencing of brain radiotherapy and targeted chemotherapy
after brain metastasis (BM) in HER2-positive breast cancer patients is limited and …

Nanoparticles Mediated the Diagnosis and Therapy of Glioblastoma: Bypass or Cross the Blood–Brain Barrier

X Song, H Qian, Y Yu - Small, 2023 - Wiley Online Library
Glioblastoma is one of the most aggressive central nervous system malignancies with high
morbidity and mortality. Current clinical approaches, including surgical resection …